cetirizine has been researched along with MS (Multiple Sclerosis) in 2 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hu, H | 1 |
Reddell, S | 1 |
Riminton, S | 1 |
Chan, C | 1 |
Urriola, N | 1 |
Conte, WL | 1 |
Arndt, N | 1 |
Cipriani, VP | 1 |
Dellaria, A | 1 |
Javed, A | 1 |
2 other studies available for cetirizine and MS (Multiple Sclerosis)
Article | Year |
---|---|
Refractory chronic spontaneous urticaria after the use of alemtuzumab in multiple sclerosis.
Topics: Adult; Alemtuzumab; Anti-Allergic Agents; Cetirizine; Chronic Urticaria; Female; Glucocorticoids; Hu | 2020 |
Reduction in ocrelizumab-induced infusion reactions by a modified premedication protocol.
Topics: Acetaminophen; Administration, Intravenous; Adult; Age Factors; Anti-Inflammatory Agents; Antibodies | 2019 |